The Tie2 antagonist rebastinib reduces ovarian cancer growth in a syngeneic murine model

Related articles

1. HO-3867 mediated modulation of Extracellular vesicles and Tumor microenvironment: A novel immunotherapeutic strategy for ovarian cancer

   This article has 12 authors:

   1. Ganesh Yadagiri
   2. Lakshmi Narasimhan Chakrapani
   3. Shyam Sundaram
   4. Jessica Velasquez
   5. Tiffany Hughes
   6. Gabriela S. Vendrell
   7. Balazs Bognar
   8. Qi-En Wang
   9. David M. O’Malley
   10. David E. Cohn
   11. Karuppaiyah Selvendiran
   12. Kalpana Deepa Priya Dorayappan

2. Anti-TNFR2 Antibody and HMGN1 Combined with TIL Cell Therapy Inhibits Colorectal Cancer Progression by Enhancing Immune Response

   This article has 13 authors:

   1. Hang Lv
   2. Yujie Nie
   3. Huan Gui
   4. Haohua Yuan
   5. Qianyu Jing
   6. Shuanghui Chen
   7. Linzhao Li
   8. Quan Wan
   9. Liming Zhao
   10. Shengwen Zhou
   11. Shuyi Wang
   12. Jia Song
   13. Yingjie Nie

3. Anti-tumor effects of MAGL inhibitor and its synergistic effects with SCD1 inhibitor in breast cancer

   This article has 9 authors:

   1. Jing Zhao
   2. Zheng Zhi
   3. Zhaoping Chu
   4. Congcong Ren
   5. Shuai Xu
   6. Nan Wu
   7. Qingxia Li
   8. Jingyi Guan
   9. Jiankang Liu